Biologics Safety Testing Market (By Product Type: Kits & Reagents, Instruments; By Application: Blood and Blood-related Products Testing, Vaccine and Therapeutics Development, Cellular and Gene Therapy, Tissue and Tissue-related Products Testing, Stem Cell Research; By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Residual Host Contamination Detection Tests, Adventitious Agent Detection Tests, Bioburden tests, Other) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Table Of Content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Biologics Safety Testing
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Biologics Safety Testing Market By Application
     1.2.2.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Application (2015-2026)
     1.2.2.2. Global Biologics Safety Testing Market Revenue Share By Application in 2017
     1.2.2.3. Vaccine and Therapeutics Development
     1.2.2.4. Blood and Blood-related Products Testing
     1.2.2.5. Cellular and Gene Therapy
     1.2.2.6. Tissue and Tissue-related Products Testing
     1.2.2.7. Stem Cell Research
   1.2.3. Biologics Safety Testing Market By Product Type
     1.2.3.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
     1.2.3.2. Global Biologics Safety Testing Market Revenue Share By Product Type in 2017
     1.2.3.3. Kits & Reagents
     1.2.3.4. Instruments
   1.2.4. Biologics Safety Testing Market By Test Type
     1.2.4.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
     1.2.4.2. Global Biologics Safety Testing Market Revenue Share By Test Type in 2017
     1.2.4.3. Sterility Tests
     1.2.4.4. Endotoxin Tests
     1.2.4.5. Cell Line Authentication and Characterization Tests
     1.2.4.6. Residual Host Contamination Detection Tests
     1.2.4.7. Adventitious Agent Detection Tests
     1.2.4.8. Bioburden tests
     1.2.4.9. Others
   1.2.5. Biologics Safety Testing Market By Geography
     1.2.5.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.5.2. North America Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)
     1.2.5.3. Europe Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)
     1.2.5.4. Asia-Pacific Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)
     1.2.5.5. Latin America Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)
     1.2.5.6. Middle East and Africa (MEA) Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Biologics Safety Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Biologics Safety Testing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Biologics Safety Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Biologics Safety Testing Major Manufacturers in 2017

CHAPTER 4. BIOLOGICS SAFETY TESTING MARKET BY APPLICATION
4.1. Global Biologics Safety Testing Revenue By Application
4.2. Vaccine and Therapeutics Development
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Blood and Blood-related Products Testing
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Cellular and Gene Therapy
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Tissue and Tissue-related Products Testing
   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Stem Cell Research
   4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. BIOLOGICS SAFETY TESTING MARKET BY PRODUCT TYPE
5.1. Global Biologics Safety Testing Revenue By Product Type
5.2. Kits & Reagents
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Instruments
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. BIOLOGICS SAFETY TESTING MARKET BY TEST TYPE
6.1. Global Biologics Safety Testing Revenue By Test Type
6.2. Sterility Tests
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Endotoxin Tests
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Cell Line Authentication and Characterization Tests
   6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Residual Host Contamination Detection Tests
   6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Adventitious Agent Detection Tests
   6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Bioburden tests
   6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.8. Others
   6.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
7.1. North America Biologics Safety Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
   7.3.1. U.S. Biologics Safety Testing Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   7.3.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   7.4.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
8.1. Europe Biologics Safety Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   8.3.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   8.4.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   8.5.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   8.6.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   8.7.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
9.1. Asia-Pacific Biologics Safety Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   9.3.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   9.4.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   9.5.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   9.6.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   9.7.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.8.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   9.8.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
10.1. Latin America Biologics Safety Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   10.3.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   10.4.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   10.5.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY
11.1. Middle East & Africa Biologics Safety Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   11.3.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.4. Saudi Africa
   11.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   11.4.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
   11.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
   11.5.3. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Charles River Laboratories
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Product Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. SGS SA
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Product Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. Lonza Group LTD
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Product Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Merck KGaA
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Product Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. WuXi Apptec
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Product Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. Thermo Fisher Scientific Inc.
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Product Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Sartorius AG
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Product Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. Cytovance Biologics, Inc.
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Product Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Pace Analytical Services Inc.
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Product Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Eurofins Scientific Se
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Product Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies
12.11. Avance Biosciences Inc.
   12.11.1. Company Snapshot
   12.11.2. Overview
   12.11.3. Financial Overview
   12.11.4. Product Portfolio
   12.11.5. Key Developments
   12.11.6. Strategies
12.12. Source Bioscience
   12.12.1. Company Snapshot
   12.12.2. Overview
   12.12.3. Financial Overview
   12.12.4. Product Portfolio
   12.12.5. Key Developments
   12.12.6. Strategies
12.13. Toxikon Corporation
   12.13.1. Company Snapshot
   12.13.2. Overview
   12.13.3. Financial Overview
   12.13.4. Product Portfolio
   12.13.5. Key Developments
   12.13.6. Strategies
12.14. Others
   12.14.1. Company Snapshot
   12.14.2. Overview
   12.14.3. Financial Overview
   12.14.4. Product Portfolio
   12.14.5. Key Developments
   12.14.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope